Commercialization: Page 57
-
PharmaVoice Team/PharmaVoice
Embedded Systems
If someone would have told you as recently as three years ago that you would be using your smartphone as much as your laptop, you might have dismissed them. The same would be true of someone telling you that you would be using a 10-inch screen with no keyboard as your only home computer, but the ...
By Chris Cullmann • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The Paradox of the Fanny Pack
Remember when — oh, some 10 to 15 years ago — when we had multiple digital devices clipped to our belts? Certain people had so many things to carry, they strapped a fashionable fanny pack around their waist to contain all of these gadgets. At the time, we were amazed by these tiny digital devices...
By Boris Kushkuley • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Reshaping the Iron Triangle: Better Software Processes For Tomorrow's Life-Sciences Technology
According to some estimates, technology is advancing at a pace of 5 million new ideas/inventions per second. As new platforms and terms such as SaaS, Big Data, and cloud abound, there is exponentially increasing pressure for software producers and consumers to keep up with the latest use of softw...
By Chris Middleton • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Understanding Protocol Complexity Produces More Accurate Investigator Site Budgets
Protocol complexity metric, also known as site work effort (SWE), measures the effort required by site staff to implement the procedures in a clinical trial protocol. This metric is based on the amount of time that it takes for the investigative site to perform a procedure called for in the proto...
By Frank Cattie • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The 6 Keys to Effective e-Detailing: Optimizing the IPAD Experience With Closed-Loop Marketing
There has never been a better time to evolve our pharmaceutical sales model beyond the typical rep/physician interaction. Studies show that in-person sales visits are declining in effectiveness. The top 40 pharmaceutical companies in the United States employ about 80,000 sales reps — doubling sin...
By Erin Byrne • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Marketing Physicians Trust
In The Tipping Point, author Malcolm Gladwell said: “The most powerful selling of products and ideas takes place not marketer to consumer but consumer to consumer." He couldn’t have been more on point. In fact, according to the latest Edelman Trust Barometer, only 20% of the people surveyed trust...
By Stephanie Brown • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Think Differently. Connect Effectively.
Take a chance, but be cautious. Do something new, but hold on to what’s familiar. Spend less, but deliver big. Be an industry leader, but show me someone else who did it first. This is the balancing act that challenges many pharmaceutical marketers today. Here’s one answer: Cookie your target aud...
By Robert Carmignani • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Find Your Target Audiences and Connect With Them
Healthcare professionals and health consumers are using digital channels more than ever before, and the medium’s popularity continues to grow each day. Pharma marketers want to connect with these audiences and are having increasing difficulty doing so as media fragments. A critical disconnect is ...
By R.J. Lewis • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: E-Solutions: E-Solutions On The Move
The fast and furious adoption of smartphones and tablet computers has created a need for more mobile, flexible e-solutions across all functions of the life-sciences enterprise. Findings from Kalorama Information’s recent report, Market for Mobile Medical Apps, valued the market for mobile medical...
By Carolyn Gretton • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Experts: Thought Leaders
Mike Ackermann, Ph.D. Senior VP, Global Commercial Solutions, Quintiles, a biopharmaceutical services company offering fully integrated clinical, commercial, consulting, and capital solutions. For more information, visit quintiles.com. Faraz Ali. VP, Program Management and Commercial Planning, b...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Global: IT
Managing Big Data in the Cloud In the midst of an information explosion, cloud computing offers a solution. In the midst of an information explosion, cloud computing offers a solution. In the midst of an information explosion, cloud computing offers a solution. The era of big data is here, and he...
By Robin Robinson • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Sales: New Strategies
Sales of the Future: New Tools, New Roles, New Strategies Salesforces target smaller audiences, with more customer service. Threatened by downsizing and mergers, disrupted by managed-care policies, and stalled by no-see physicians — the list on the challenges facing today’s sales reps goes on and...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Marketing: Public Relations
PR Goes Digital With the advent of digital media, the role of public relations has a greater responsibility to manage and protect a company’s reputation, while increasing visibility. According to Rob Bazemore, president, Janssen Biotech, PR plays a valuable role in building and maintaining the vi...
By Robin Robinson • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Marketing: Digital Media
Using Digital Media Wisely Campaigns need to follow objectives, not channels Experts say creating an experience for patients that allows them to engage with a company beyond its therapies is the most effective use of social media, delivering meaningful information to both the patient and the orga...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Marketing: New Strategies
Digital Marketing: Driving New Strategies in 2013 Increasing interest and investment rev up digital channel use. According to reports from Cutting Edge Information, pharmaceutical companies have been increasing their investment in digital marketing strategies over the past three years, and growth...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: The New Paradigm
The New R&D Paradigm The industry needs to continue developing innovative drugs to address high unmet needs, while addressing the speed and quality of drug discovery, development, and commercialization. Large and small biopharma companies are seeking to increase the efficiency and productivit...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The C-Suite: Corporate Strategies
A New Path Ahead According to a recent Quintiles New Health report, a lack of capital and the increased reluctance of payers to reimburse for new medications are serious concerns among biopharma companies. Everyone is in agreement that the current level of healthcare spending is unsustainable, an...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The C-Suite: Executive Insights
Executive Insights CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the ...
By Taren Grom • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Crystal Ball: What's Ahead
Getting Down to Business: What’s Ahead in 2013 Thought leaders from all sectors of the industry identify what they believe are the most important business objectives for the life-sciences industry and their companies for 2013 and beyond. They also provide their insights on the strategies/approac...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The Year Ahead: Forging New Paths
Forging New Paths Ever-changing market dynamics will create an industry that is unlike the one we have today. 2013 promises to be as tumultuous as 2012, as the industry looks to contend with the political ping-pong ball that is healthcare. Faced with myriad internal and external pressures, life-s...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharmaceutical POOL Stuart Arbuckle Former Amgen VP Joins Vertex Vertex Pharmaceuticals has appointed Stuart Arbuckle as executive VP and chief commercial officer. Mr. Arbuckle most recently served as Amgen’s VP and regi...
By PharmaVoice Team • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Social Media, Mobile & Gaming for Pharma: How To Develop, Monitor, & Execute Digital Strategies To Engage Your Audiences, Strengthen Brand Awareness & Maximize Your Communication & Marketi...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Enlight’s Knode Partners with AstraZeneca Trend: Knode is working with leading pharma companies, academics, and researchers to develop Web-based solutions for accessing life-sciences experts and their knowledge. AstraZeneca is collaborating with Enlight Biosciences’ portfolio company, Knode, in t...
By Carolyn Gretton • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
What's New
Trend: The adoption of digital platforms for gathering and consuming content has removed the traditional expert middlemen who controlled and interpreted information. The multiplatform content group (MCG) at Chandler Chicco Companies (CCC) uses storytelling know-how and expertise in the science of...
By Carolyn Gretton • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Honored by Working Mother Bayer has been recognized by Working Mother magazine as one of the nation’s 100 best companies for working mothers. This is the ninth time in the past 10 years the company has been recognized on the annual list Clinical Research Advantage Executive Honorod Clinic...
By Taren Grom • Nov. 8, 2012
Previous
